Read on Twitter
CORRECTED THREAD: from the Global Provider-entered Registry (EULAR registry not included)
Total = 146 patients; 23% are male/77% female, 18% are age 65+.
7 patients are deceased.
Top 3 COVID symptoms: 75% cough, 73% fever, 52% shortness of breath; 37% had all three of these
Total = 146 patients; 23% are male/77% female, 18% are age 65+.
7 patients are deceased.
Top 3 COVID symptoms: 75% cough, 73% fever, 52% shortness of breath; 37% had all three of these
Top 5 conditions: 36% Rheumatoid Arthritis, 17% Lupus, 10% Psoriatic Arthritis, 8% Ankylosing Spondylitis, 8% Sjogren’s
69% on conventional DMARD (25% on hydroxychloroquine), 39% on biologic DMARD, 5% on JAKi
31% on glucocorticoids, 27% on NSAIDs
69% on conventional DMARD (25% on hydroxychloroquine), 39% on biologic DMARD, 5% on JAKi
31% on glucocorticoids, 27% on NSAIDs
Total= 36 COVID infected patients on hydroxychloroquine (~25% of total patients)
14% are male/86% female, 11% are age 65+.
2 patients are deceased.
Top 5 conditions: 36% RA, 44% SLE, 14% Sjogren’s
14% are male/86% female, 11% are age 65+.
2 patients are deceased.
Top 5 conditions: 36% RA, 44% SLE, 14% Sjogren’s
HCQ specifically:
53% on other conventional DMARD (besides HCQ), 19% on biologic DMARD, 3% on JAKi. 14 patients (39%) are on no other immune modulating medication.
33% on glucocorticoids, 21% on NSAIDs
53% on other conventional DMARD (besides HCQ), 19% on biologic DMARD, 3% on JAKi. 14 patients (39%) are on no other immune modulating medication.
33% on glucocorticoids, 21% on NSAIDs
(previously we reversed the percent of female/male)
